Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Economou

Showing results (111-120 of 151) with videos related to

Pageof 16
Sort By:
Cancer Gene Therapy|January 1, 1997
A comparison of gene transfer methods in human dendritic cellsJ F Arthur, L H Butterfield, M D Roth, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cellsA Ribas, L H Butterfield, B Hu, et al.
Journal of Translational Medicine|April 7, 2019
Interleukin 32 expression in human melanomaHelicia Paz, Jennifer Tsoi, Anusha Kalbasi, et al.
Cancer Discovery|June 15, 2018
Immunotherapy Resistance by Inflammation-Induced DedifferentiationArnav Mehta, Yeon Joo Kim, Lidia Robert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancerLisa H Butterfield, Antoni Ribas, Wilson S Meng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 7, 2004
Enhanced tumor responses to dendritic cells in the absence of CD8-positive cellsAntoni Ribas, Jennifer A Wargo, Begonya Comin-Anduix, et al.
Immunology|November 24, 2004
Antigen presentation by MART-1 adenovirus-transduced interleukin-10-polarized human monocyte-derived dendritic cellsShikhar Mehrotra, Arvind Chhabra, Abolokita Chakraborty, et al.
The Journal of Clinical Investigation|January 15, 1996
In vivo trafficking of adoptively transferred interleukin-2 expanded tumor-infiltrating lymphocytes and peripheral blood lymphocytes. Results of a double gene marking trialJ S Economou, A S Belldegrun, J Glaspy, et al.
Cancer Research|December 26, 2001
CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cellsA Ribas, L H Butterfield, S N Amarnani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
Immunosensitization of tumor cells to dendritic cell-activated immune responses with the proteasome inhibitor bortezomib (PS-341, Velcade)Lana Y Schumacher, Dan D Vo, Hermes J Garban, et al.
Pageof 16

Showing results (111-120 of 151) with videos related to

Sort By:
Pageof 16
Cancer Gene Therapy|January 1, 1997
A comparison of gene transfer methods in human dendritic cellsJ F Arthur, L H Butterfield, M D Roth, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cellsA Ribas, L H Butterfield, B Hu, et al.
Journal of Translational Medicine|April 7, 2019
Interleukin 32 expression in human melanomaHelicia Paz, Jennifer Tsoi, Anusha Kalbasi, et al.
Cancer Discovery|June 15, 2018
Immunotherapy Resistance by Inflammation-Induced DedifferentiationArnav Mehta, Yeon Joo Kim, Lidia Robert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancerLisa H Butterfield, Antoni Ribas, Wilson S Meng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 7, 2004
Enhanced tumor responses to dendritic cells in the absence of CD8-positive cellsAntoni Ribas, Jennifer A Wargo, Begonya Comin-Anduix, et al.
Immunology|November 24, 2004
Antigen presentation by MART-1 adenovirus-transduced interleukin-10-polarized human monocyte-derived dendritic cellsShikhar Mehrotra, Arvind Chhabra, Abolokita Chakraborty, et al.
The Journal of Clinical Investigation|January 15, 1996
In vivo trafficking of adoptively transferred interleukin-2 expanded tumor-infiltrating lymphocytes and peripheral blood lymphocytes. Results of a double gene marking trialJ S Economou, A S Belldegrun, J Glaspy, et al.
Cancer Research|December 26, 2001
CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cellsA Ribas, L H Butterfield, S N Amarnani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
Immunosensitization of tumor cells to dendritic cell-activated immune responses with the proteasome inhibitor bortezomib (PS-341, Velcade)Lana Y Schumacher, Dan D Vo, Hermes J Garban, et al.
Pageof 16